betaxolol has been researched along with Tachycardia in 2 studies
Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
Excerpt | Relevance | Reference |
---|---|---|
" Very mild eye irritation, which was less than that of betaxolol hydrochloride, was observed particularly with BMO maleate, which is an excellent candidate for safe treatment of glaucoma." | 5.30 | Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma. ( Barros, MD; Bodor, N; Farag, HH; Prokai, L; Somogyi, G; Wu, WM, 1997) |
"Autonomic neural responses to betaxolol are age-dependent in hypertension-related tachycardia." | 3.88 | Age-dependent sympathetic neural responses to ß ( Chrostowska, M; Hering, D; Kucharska, W; Narkiewicz, K, 2018) |
" Very mild eye irritation, which was less than that of betaxolol hydrochloride, was observed particularly with BMO maleate, which is an excellent candidate for safe treatment of glaucoma." | 1.30 | Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma. ( Barros, MD; Bodor, N; Farag, HH; Prokai, L; Somogyi, G; Wu, WM, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hering, D | 1 |
Kucharska, W | 1 |
Chrostowska, M | 1 |
Narkiewicz, K | 1 |
Farag, HH | 1 |
Wu, WM | 1 |
Barros, MD | 1 |
Somogyi, G | 1 |
Prokai, L | 1 |
Bodor, N | 1 |
2 other studies available for betaxolol and Tachycardia
Article | Year |
---|---|
Age-dependent sympathetic neural responses to ß
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Age Factors; Betaxolol; Blood Pressure; Heart Rate; H | 2018 |
Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Eye; Glaucoma; Intraocular | 1997 |